Composite end points in randomized trials: there is no free lunch.
Tomlinson
George
G
Department of Health Policy Management and Evaluation, University of Toronto, Ontario, Canada.
Detsky
Allan S
AS
D003657:Decision Making; D003920:Diabetes Mellitus / Q000401:mortality / Q000517:prevention & control; D023381:Endpoint Determination; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone